Statistical analyses and sample size
Relative bioavailability analysis of the tablet formulation relative to the PIC formulation was performed by an analysis of variance on CIt was calculated that approximately 14–16 PK-evaluable patients were required; the sample size calculation was based on the expected 2-sided 90% CI for the difference in the paired, log-transformed AUC (or C